Osteoporosis

NattoPharma’s MenaQ7® to significantly reduce bone loss and risk for osteoporosis: Significant commercial opportunities

27th March 2013 Oslo, Norway. NattoPharma announced yesterday the publication of a groundbreaking new study on its proprietary MenaQ7® brand of Natural Vitamin K2 standardized to MK-7 content in the leading journal Osteoporosis International.

Prominent mammography provider in Germany joins fight against osteoporosis

The German mammography provider Radiologie Hofheim is the first clinic in the national mammography screening program in Germany to offer women the opportunity of a health control with osteoporosis detection. The assessment of bone health is made possible by Sectra’s patented online service, Sectra OneScreen.

Rise in Spine Bone Fractures Due to Steroid Injections

A new study conducted by the Henry Ford Hospital shows that epidural steroid injections used to alleviate pain may put patients at a greater risk of bone fractures in the spine.

Rise in Spine Bone Fractures Due to Steroid Injections

A new study conducted by the Henry Ford Hospital shows that epidural steroid injections used to alleviate pain may put patients at a greater risk of bone fractures in the spine.

How Alkaline Water Advantages Your Immune Protection System

The meals the contaminated atmosphere you and you eat up breathe, produce a large amount of acid spend within your body. As many pollutants are contained by it, chlorine, fluorine and different nutrients in it actually the plain tap water that involves your house isn't secure. Eating alkaline water enhances your immune protection system and advantages your wellbeing.

Mirabai Holland Releases New Title in Acclaimed Skeletal Fitness DVD Series

Mirabai Holland (“Mirabai”), creator of the acclaimed Skeletal Fitness® Osteoporosis Exercise Program, has expanded the scope of her best-selling bone-loading strength workout with the release of a second DVD in the Skeletal Fitness series.

Calcitonin Linked to an Increased Cancer Risk

The European Medicines Agency (EMA) warned that calcitonin-containing medicines should only be used for short-term treatment because of evidence that long-term use of these medicines is associated with an increased risk of cancer.

Syndicate content